Cogstate Limited provided earnings guidance for the he full year ended 30 June 2023. For the year, the company expects revenue to be in the range of $39 million - $41 million (9% - 12% below FY22); EBIT, from normal operations, is expected to be in the range of $1.0 million - $2.0 million; Net Profit before Tax, including restructure costs and interest revenue, is expected to be in the range of $0.6 million - $1.6 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.395 AUD | +1.82% | +7.31% | -3.46% |
Apr. 01 | Cogstate Amends License Agreement with Eisai for Alzheimer’s Treatment | MT |
Feb. 22 | Cogstate's Fiscal H1 Attributable Profit Jumps, Revenue Rises 3%; Shares Decline 8% | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.46% | 153M | |
+2.45% | 42.75B | |
+47.70% | 41.61B | |
+11.87% | 41.34B | |
-8.83% | 26.59B | |
+7.04% | 25.49B | |
-22.66% | 18.12B | |
+30.65% | 12.24B | |
-1.90% | 11.76B | |
+9.19% | 11B |
- Stock Market
- Equities
- CGS Stock
- News Cogstate Limited
- Cogstate Limited Provides Revenue Guidance in the Fourth Quarter 2023